Anticollagen antibodies and immune response gene products in rheumatoid arthritis
β Scribed by David H. Collier; S. S. Kerwar; Marvin R. Garovoy; Kenneth H. Fye; John D. Stobo
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 781 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Circulating antibodies to native and denatured types I and I1 human and bovine collagens were assayed in patients with rheumatoid arthritis (RA), patients with other rheumatic diseases, and normal individuals. A subgroup of this population was also assayed for reactivity with typing reagents which detect determinants (MT and HLA-DR) present in human immune response gene products. The mean titers of antibodies to each collagen tested were not significantly higher in RA patients when compared with patients who had other rheumatic diseases. Although both MT3 and MT4 were significantly associated with RA, there was no significant association between the anticollagen antibodies and any MT type or HLA-DR4. These studies raise a question concerning From the
π SIMILAR VOLUMES
## Abstract Materials with the Clq binding properties of soluble immune complexes (IC) were found in sera from 11 of 51 consecutive (22%) children with juvenile rheumatoid arthritis (JRA) and in 17 of 20 adults with active seroβpositive rheumatoid arthritis (RA). IC appeared more frequently in chil
## Abstract ## Objective The evolution of the rheumatoid arthritis (RA)βspecific antiβcyclic citrullinated peptide (antiβCCP) antibody response, as measured by the isotypes of antiβCCP, has not been described. This study was undertaken to determine antiβCCP isotype usage in patients with undiffere